Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature
Immune checkpoint inhibitors (ICI) are a novel class of antineoplastic treatment that enhances immunity against tumors.
Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
We studied a subset of patients with autopsy-confirmed multiple system atrophy who presented a clinical picture that closely resembled either Parkinson’s disease or progressive supranuclear palsy.
Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy
Development of autonomic failure is associated with more rapid disease course and shorter survival in patients with Parkinson’s disease and multiple system atrophy.
Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study
Corticobasal syndrome (CBS) is a progressive neurological disorder related to multiple underlying pathologies, including four-repeat tauopathies, such as corticobasal degeneration and progressive supranuclear palsy, and Alzheimer's disease (AD).
Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome
Corticobasal syndrome (CBS) is associated with diverse underlying pathologies, including the four-repeat (4R)-tauopathies.
Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
Immune checkpoint inhibitors (ICI) are a novel class of antineoplastic treatment that enhances immunity against tumors.